Sections

ideals

Business Essentials for Professionals



Companies

Corporate Diversity Under Legal Scrutiny as Nike’s Employment Practices Draw Federal Attention

Nike’s confrontation with U.S. regulators marks a pivotal moment in the widening national debate over how far corporate diversity policies can go before colliding with long-standing anti-discrimination law. What began as an internal review of workplace practices has evolved into a high-stakes...

From Catch-Up to Control: How Google Turned Scale, Infrastructure, and Integration into AI Leadership

For much of the early generative AI boom, Google was cast as an incumbent struggling to adapt. Rivals appeared faster, louder, and more willing to take risks, while Google seemed weighed down by its own scale and caution. That narrative has now decisively shifted. Alphabet, Google’s parent, has...

From Launchpads to Orbits: Musk’s Vertical AI Bet on Space-Based Computing

The merger of SpaceX and xAI marks more than a corporate restructuring. It signals an attempt to redraw the physical boundaries of digital infrastructure itself. By binding a rocket company to an artificial intelligence venture, Elon Musk is advancing a thesis that once belonged to science fiction:...

When AI Meets Orbit: Musk’s Expanding Tech Empire Tests Governance, Safety, and Strategy

The decision to fold xAI into SpaceX marks a pivotal moment in Elon Musk’s long-running effort to consolidate his ventures into a single, tightly linked ecosystem. The record-setting acquisition brings together a capital-intensive space and satellite business with a fast-scaling artificial...

AstraZeneca’s Strategic Bet on China Signals a New Phase in the Global Obesity Drug Race

The decision by AstraZeneca to commit up to $18.5 billion to license weight-loss and metabolic drug candidates from CSPC Pharmaceutical Group marks a decisive shift in how Western drugmakers are sourcing innovation in one of the most competitive therapeutic markets in decades. Far from being a...

Heavy AI Investment Tests Investor Confidence as Microsoft Faces the Cost Curve

Microsoft’s latest earnings cycle has exposed a growing tension at the heart of the artificial-intelligence boom: the gap between unprecedented capital spending and the pace at which that spending converts into visible revenue growth. While the company continues to position itself as a long-term...

Automation-Driven Restructuring Marks Nike’s Shift Toward Leaner Growth

Nike’s decision to eliminate 775 jobs in the United States reflects a deliberate recalibration of how the company intends to operate in a slower, more competitive global sportswear market. Rather than treating the layoffs as a one-off response to weak sales, the move signals a deeper strategic...

U.S. Consumer Fatigue Weighs on Procter & Gamble as Domestic Growth Falters

Procter & Gamble’s latest quarterly performance underscores how shifts in U.S. consumer behavior can ripple through even the most resilient global companies. While the consumer goods giant continues to demonstrate pricing power and strength in premium categories, slower growth in its largest...

Streaming’s Strategic Pivot: How Netflix Is Rewriting Its Playbook to Justify a Warner Bros Bet

Netflix’s defence of its bid for Warner Bros Discovery has become a proxy for a much larger strategic debate unfolding inside the global media industry. The sharp drop in the company’s share price following an otherwise solid earnings report underscored investor unease, but the reasoning Netflix’s...

Heritage Meets Youth: How Burberry’s China Strategy Turned Gen Z Momentum into Holiday Sales Strength

Burberry’s stronger-than-expected holiday performance marks more than a seasonal rebound for a luxury house emerging from a prolonged industry slowdown. It reflects a strategic recalibration that has aligned heritage, product focus, and localised storytelling with the tastes and behaviours of...

Why Price Stability Has Become the Core Strategy for IKEA’s Largest Retailer in an Unsettled Consumer Economy

For the world’s largest IKEA retailer, the lesson of the past five years has been clear: shoppers are no longer simply hunting for the lowest possible price, but for reassurance that prices will not swing unpredictably from one season to the next. After a period marked by pandemic shocks, inflation...

From Obscurity to Strategic Prize: Why a Breakout Biotech Has Drawn Takeover Attention

A little-known European biotech’s meteoric rise has become a case study in how scientific validation, market timing, and industry pressure can rapidly transform a niche player into a strategic prize. After years of relative anonymity, Abivax vaulted into the spotlight following clinical results...
1 2 3 4 5 » ... 265